Hexagon Capital Partners’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$257K Buy
3,288
+947
+40% +$76.4K 0.04% 221
2026
Q1
$203K Buy
+2,341
New +$224K 0.03% 245
2025
Q2
Sell
-3,181
Closed -$286K 1043
2025
Q1
$286K Sell
3,181
-375
-11% -$33.6K 0.05% 164
2024
Q4
$284K Buy
3,556
+456
+15% +$39.5K 0.05% 160
2024
Q3
$279K Sell
3,100
-6
-0.2% -$505 0.05% 165
2024
Q2
$244K Buy
3,106
+244
+9% +$20K 0.05% 171
2024
Q1
$249K Sell
2,862
-396
-12% -$33.8K 0.06% 169
2023
Q4
$268K Buy
3,258
+456
+16% +$34.8K 0.06% 155
2023
Q3
$220K Sell
2,802
-229
-8% -$19.2K 0.06% 160
2023
Q2
$267K Buy
3,031
+273
+10% +$23.5K 0.07% 132
2023
Q1
$222K Buy
2,758
+142
+5% +$11.6K 0.06% 149
2022
Q4
$203K Buy
2,616
+757
+41% +$61.4K 0.06% 152
2022
Q3
$150K Buy
1,859
+573
+45% +$51.5K 0.04% 183
2022
Q2
$115K Buy
1,286
+334
+35% +$33.8K 0.03% 246
2022
Q1
$106K Buy
952
+3
+0.3% +$317 0.03% 265
2021
Q4
$98K Buy
949
+80
+9% +$9.26K 0.03% 273
2021
Q3
$109K Buy
869
+20
+2% +$2.59K 0.03% 236
2021
Q2
$105K Hold
849
0.03% 245
2021
Q1
$100K Sell
849
-105
-11% -$12.3K 0.03% 230
2020
Q4
$111K Hold
954
0.03% 173
2020
Q3
$97K Buy
+954
New +$95.8K 0.03% 180

Other funds holding MDT

Hexagon Capital Partners's MDT Position: Q2 2026 in Review

Hexagon Capital Partners increased its Medtronic (MDT) stake by 40% in Q2 2026, buying an estimated $76.4K and bringing the position to 3,288 shares worth $257K. The position accounts for 0.04% of the portfolio, ranked #221.

Hexagon Capital Partners first reported a position in MDT in Q3 2020 and has held it in 21 quarters since. The position peaked at $286K in Q1 2025. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Hexagon Capital Partners held 3,288 shares of Medtronic worth $257K as of Q2 2026.
  • Hexagon Capital Partners bought 947 Medtronic shares in Q2 2026, an estimated $76.4K.
  • Medtronic made up 0.04% of Hexagon Capital Partners's portfolio in Q2 2026, its #221 holding.
  • Hexagon Capital Partners first reported a position in Medtronic in Q3 2020 and has held it in 21 quarters since.
  • Hexagon Capital Partners's Medtronic position peaked at $286K in Q1 2025.
  • 2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Hexagon Capital Partners's 13F filing for Q2 2026, filed 7 Aug 2026.